weight loss surgery vs glp-1 GLP-1s Vs. Bariatric For Medication vs. Bariatric Surgery for

This provides us with a comprehensive view, not just a snapshot, of your health

Clinically, visceral fat accumulation is often assessed through waist circumference measurements, with values exceeding 40 inches (102 cm) in men and 35 inches (88 cm) in women indicating increased cardiometabolic risk according to the American Heart Association/National Heart, Lung, and Blood Institute criteria

Downstream, la activacin de GLP-1R/GIP-R aumenta cAMP intracelular, fosforila PKA y CREB, e induce expresin de genes de supervivencia -pancretica (PDX-1, MafA)

These discussions highlight real barriers to medication access that dont exist in US-focused forums, making Canadian perspectives particularly valuable for understanding practical treatment challenges

Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025

In trials like SURMOUNT, Tirzepatide (15 mg weekly) achieved impressive results, showing approximately 20-21% mean weight loss over about 72 weeks